Inter Parfums
IPAR Nasdaq Household Products Financials FY2016βFY2025
Inter Parfums' revenue rose 2.5% to $1.5 billion in fiscal 2025. Its operating margin was 18.2%, down from 18.9% a year earlier. Free cash flow was $190 million, up 4.2%. It paid out $117 million in dividends and buybacks, 61% of free cash flow.
What Inter Parfums does
No business description yet.
- Legal name
- INTERPARFUMS, INC.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001753926-26-000464
0000822663
Revenue and margins
Inter Parfums had $1.5B of revenue in fiscal 2025, up 2.5% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 19.3% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $190M in fiscal 2025, 12.8% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Inter Parfums returned $117M to shareholders in fiscal 2025, 61% of free cash flow. The diluted share count rose 0.0%.
Value Inter Parfums yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β and divides by 32.1M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 22.0x Β· peers 16.8x Β· sector 24.7x.
Balance sheet
Cash, debt and the ratios that show how comfortably Inter Parfums can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $159.8B | β | β | β | β |
| Debt incl. finance leases | $149M | $180M | $162M | $166M | $185M |
| Net debt / EBITDA | β993.0x | β | β | β | β |
| Debt / equity | 0.3x | 0.3x | 0.2x | 0.2x | 0.2x |
| Interest coverage | 52.4x | 54.0x | 22.3x | 35.1x | 37.3x |
| Current ratio | 2.9x | 2.3x | 2.6x | 2.8x | 3.0x |
| Quick ratio | 2.1x | 1.4x | 1.4x | 1.7x | 2.0x |
| Total assets | $1.1B | $1.3B | $1.4B | $1.4B | $1.6B |
| Total liabilities | $407M | $520M | $477M | $469M | $481M |
| Shareholders' equity | $572M | $617M | $699M | $745M | $881M |
| Net debt (β = net cash) | β$159.6B | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$4.0M
3 insiders
Of sales under plans
0%
$0.0M
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 6 / 9 | 9 / 9 | 4 / 9 |
| Accruals ratio | 3.5% | β1.7% | β3.1% |
| Altman Z'' | 7.31 | 7.94 | 8.09 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Inter Parfums IPAR | $3.7B | 2.5% | 18.2% | 12.8% | β | 22.0x | 4 | |
| Edgewell Personal Care EPC | $1.3B | β1.3% | 4.3% | 1.9% | 3.6% | β | 5 | Compare β |
| Spectrum Brands SPB | $1.8B | β5.2% | 4.5% | 5.9% | 5.3% | 25.2x | 6 | Compare β |
| Energizer ENR | $1.6B | 2.3% | β | 2.1% | 11.1% | 6.8x | 7 | Compare β |
| Central Garden & Pet CENT | $2.8B | β2.2% | 8.0% | 9.3% | 9.7% | 16.8x | 8 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $521M | $591M | $676M | $714M | $539M | $880M | $1.1B | $1.3B | $1.5B | $1.5B |
| Gross profit | $327M | $376M | $428M | $446M | $331M | $557M | $694M | $839M | $927M | $947M |
| Operating income | $66.7M | $78.6M | $94.7M | $105M | $70.1M | $148M | $194M | $251M | $275M | $270M |
| Interest expense | $2.3M | $2.0M | $2.6M | $2.1M | $2.0M | $2.8M | $3.6M | $11.3M | $7.8M | $7.2M |
| Pretax income | $67.1M | $78.1M | $95.9M | $105M | $69.3M | $151M | $194M | $250M | $268M | $271M |
| Income tax | $23.8M | $22.8M | $26.1M | $29.1M | $19.4M | $41.0M | $43.2M | $61.8M | $65.0M | $63.2M |
| Net income | $33.3M | $41.6M | $53.8M | $60.2M | $38.2M | $87.4M | $121M | $153M | $164M | $168M |
| Diluted EPS | $1.07 | $1.33 | $1.71 | $1.90 | $1.21 | $2.75 | $3.78 | $4.75 | $5.12 | $5.24 |
| Diluted shares | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B |
| Cash flow | ||||||||||
| Cash from operations | $54.6M | $35.9M | $63.0M | $76.5M | $65.0M | $120M | $73.0M | $106M | $188M | $215M |
| Capital expenditure | $4.8M | $3.0M | $4.0M | $5.4M | $11.0M | $141M | $33.8M | $6.5M | $4.7M | $24.4M |
| Free cash flow | $49.8M | $32.9M | $59.1M | $71.0M | $54.0M | β$21.7M | $39.3M | $99.3M | $183M | $190M |
| Depreciation and amortization | $3.7M | $3.8M | $4.1M | $3.7M | $9.1M | $12.7M | $22.5M | $17.3M | $28.4M | $25.3M |
| Stock-based compensation | $1.2M | $2.1M | $2.2M | $3.4M | $3.0M | $2.9M | $3.1M | $2.5M | $2.4M | $1.6M |
| Acquisitions | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $0.1M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $15.4M | $0.0M | $13.9M |
| Dividends paid | $18.0M | $21.2M | $26.3M | $34.6M | $20.8M | $31.7M | $63.7M | $80.0M | $96.0M | $103M |
| Dividends and buybacks | $18.1M | $21.2M | $26.3M | $34.6M | $20.8M | $31.7M | $63.7M | $95.4M | $96.0M | $117M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $256M | $278M | $261M | $253M | $170M | $159.8B | β | β | β | β |
| Total debt | $74.6M | $60.6M | $46.1M | $23.1M | $24.7M | $149M | $180M | $162M | $166M | $185M |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $472M | $549M | $572M | $573M | $601M | $710M | $788M | $839M | $926M | $1.0B |
| Current liabilities | $142M | $167M | $189M | $185M | $156M | $245M | $345M | $325M | $332M | $344M |
| Inventory | $97.0M | $137M | $162M | $168M | $159M | $199M | $290M | $372M | $372M | $351M |
| Property and equipment, net | $10.1M | $10.3M | $9.8M | $11.1M | $19.6M | $149M | $167M | $169M | $154M | $185M |
| Total assets | $682M | $778M | $798M | $829M | $890M | $1.1B | $1.3B | $1.4B | $1.4B | $1.6B |
| Total liabilities | $199M | $207M | $212M | $220M | $188M | $407M | $520M | $477M | $469M | $481M |
| Shareholders' equity | $370M | $433M | $448M | $468M | $536M | $572M | $617M | $699M | $745M | $881M |
| Margins | ||||||||||
| Gross margin | 62.7% | 63.6% | 63.3% | 62.5% | 61.4% | 63.3% | 63.9% | 63.7% | 63.9% | 63.6% |
| Operating margin | 12.8% | 13.3% | 14.0% | 14.7% | 13.0% | 16.8% | 17.9% | 19.1% | 18.9% | 18.2% |
| EBITDA margin | 13.5% | 13.9% | 14.6% | 15.2% | 14.7% | 18.3% | 20.0% | 20.4% | 20.9% | 19.9% |
| Net margin | 6.4% | 7.0% | 8.0% | 8.4% | 7.1% | 9.9% | 11.1% | 11.6% | 11.3% | 11.3% |
| FCF margin | 9.6% | 5.6% | 8.8% | 10.0% | 10.0% | β2.5% | 3.6% | 7.5% | 12.6% | 12.8% |
| Returns | ||||||||||
| Return on capital | 13.9% | 17.0% | 19.0% | 20.2% | 10.8% | β | β | β | β | β |
| Return on capital employed | 12.2% | 13.7% | 15.5% | 16.7% | 10.2% | 18.1% | 20.8% | 25.0% | 25.9% | 23.3% |
| Return on equity | 9.1% | 10.4% | 12.2% | 13.2% | 7.6% | 15.8% | 20.4% | 23.2% | 22.8% | 20.7% |
| Return on assets | 4.9% | 5.7% | 6.8% | 7.4% | 4.5% | 8.6% | 9.9% | 11.4% | 11.8% | 11.2% |
| Growth | ||||||||||
| Revenue growth | 11.2% | 13.5% | 14.3% | 5.6% | β24.5% | 63.2% | 23.6% | 21.3% | 10.2% | 2.5% |
| Net income growth | 9.5% | 24.8% | 29.3% | 12.0% | β36.6% | 128.7% | 38.4% | 26.2% | 7.7% | 2.5% |
| EPS growth | 9.2% | 24.3% | 28.6% | 11.1% | β36.3% | 127.3% | 37.5% | 25.7% | 7.8% | 2.3% |
| FCF growth | 8.4% | β34.0% | 79.8% | 20.2% | β24.0% | β140.2% | β | 152.9% | 84.2% | 4.2% |
| Share count change | 0.2% | 0.4% | 0.7% | 0.5% | β0.1% | 0.6% | 0.5% | 0.5% | β0.1% | 0.0% |
| Financial health | ||||||||||
| Net debt / EBITDA | β2.6x | β2.6x | β2.2x | β2.1x | β1.8x | β993.0x | β | β | β | β |
| Debt / equity | 0.2x | 0.1x | 0.1x | 0.1x | 0.1x | 0.3x | 0.3x | 0.2x | 0.2x | 0.2x |
| Interest coverage | 28.5x | 39.5x | 36.8x | 48.8x | 35.6x | 52.4x | 54.0x | 22.3x | 35.1x | 37.3x |
| Current ratio | 3.3x | 3.3x | 3.0x | 3.1x | 3.9x | 2.9x | 2.3x | 2.6x | 2.8x | 3.0x |
| Quick ratio | 2.6x | 2.5x | 2.2x | 2.2x | 2.8x | 2.1x | 1.4x | 1.4x | 1.7x | 2.0x |
| Capital allocation | ||||||||||
| Capex / revenue | 0.9% | 0.5% | 0.6% | 0.8% | 2.0% | 16.1% | 3.1% | 0.5% | 0.3% | 1.6% |
| Stock comp / revenue | 0.2% | 0.4% | 0.3% | 0.5% | 0.6% | 0.3% | 0.3% | 0.2% | 0.2% | 0.1% |
| Payouts / FCF | 36.3% | 64.5% | 44.5% | 48.7% | 38.5% | β | 162.3% | 96.1% | 52.5% | 61.2% |
| Quality scores | ||||||||||
| Piotroski F-score | 5.0 | 6.0 | 6.0 | 7.0 | 5.0 | 6.0 | 4.0 | 6.0 | 9.0 | 4.0 |
| Altman Z'' | 8.3 | 8.6 | 8.7 | 8.7 | 9.6 | 7.0 | 6.4 | 7.3 | 7.9 | 8.1 |
| Accruals ratio | β3.1% | 0.8% | β1.2% | β2.0% | β3.1% | β3.2% | 3.9% | 3.5% | β1.7% | β3.1% |
Source: SEC EDGAR XBRL filings (CIK 0000822663). Data updated October 20, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.